Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Detention of 2 DPP ex-staffers in China espionage case extended
04/17/2025 09:59 PM - Politics
Ko Wen-je says he was improperly interrogated, calls for video release
04/17/2025 07:32 PM - Business
TSMC denies rumors about joint venture with Intel
04/17/2025 07:07 PM - Society
Taiwan headline news
04/17/2025 06:25 PM - Politics
Lai calls for more trade cooperation with NZ amid global challenges
04/17/2025 06:17 PM